FindTrial
Sign In

Study of effect of a drug given in spinal anesthesia in high risk patients coming for lower limb operations

Selective spinal analgesia using 0.2% plain ropivacaine for unilateral lower limb surgeries in high risk patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021131
Enrollment
100
Registered
2019-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: Selective spinal analgesia using 0.2% plain ropivacaine for unilateral lower limb surgeries in high risk patients: In high risk patients posted for lower limb surgeries , 2.5 ml of 0.2

Sponsors

DrAshwini A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Relative contraindication for general anesthesia

Exclusion criteria

Exclusion criteria: Patient on any anticoagulant therapy Patient with coagulation disorders

Design outcomes

Primary

MeasureTime frame
Using low dose 0.2% plain ropivacaine provides better sensory block and hemodynamic stability in ASA grade 3 patients .Timepoint: Patient is observed from the start of procedure till recovery from anesthesia—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactAshwini A

KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES

dr.ashwinivijay.a@gmail.com9880490917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026